Cite
HARVARD Citation
Gelbmann, N. et al. (2019). Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) – Biochemical characterization, pathogen safety, and stability. Biologicals. pp. 60-67. [Online].